Navigation Links
AstraZeneca Neuroscience partners with ePharmaSolutions to optimize Clinical Trial Management
Date:6/10/2013

CONSHOHOCKEN, Pa., June 10, 2013 /PRNewswire/ -- ePharmaSolutions, a leading clinical services and eClinical solutions provider, has signed a deal with AstraZeneca Neuroscience Innovative Medicines (AZ NS iMed), to provide IT solutions that will enable the iMed to share and manage complex data on a common portal with clinical trial investigators and other external partners.  The ePharmaSolutions integrated clinical trial portal will also feature an electronic trial master file (eTMF) solution and cloud technology for sharing documents securely. Initially, the ePharmaSolutions technology will be used to manage three separate neuroscience clinical trials.

AstraZeneca's Neuroscience iMed is a unique model in the pharma industry – a core of about 40 neuroscientists managing a portfolio of drug discovery and development projects solely with external partners.  Since it was created just over a year ago, the iMed has strived to implement innovative technologies that enable it to work seamlessly – quickly and efficiently – with investigators, contract research organizations, academic researchers and regulatory authorities.  "A key strategy for our business is crafted around relationship building and leveraging innovative solutions for data sharing with collaborators," said Steven Leventer, PhD, VP, AZ NS iMed. "The capabilities brought to the table by ePharmaSolutions are aimed at enabling the AZ NS iMed to ramp up our clinical trial sites more quickly and efficiently."

"We are very pleased to have been selected by the AZ NS iMed team for this collaboration," adds Lance Converse, founder and CEO of ePharmaSolutions. "Our integrated trial portal, document exchange and eTMF platform will play a pivotal role in supporting the study teams as well as the investigator sites."

About ePharmaSolutions

ePharmaSolutions is a leading provider of eClinical solutions that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions has won multiple Bio-IT World Award for best clinical trial technology and has activated and trained more than 300,000 clinical researchers in 130 countries for the top 20 pharmaceutical companies and CROs in the world. ePharmaSolutions is headquartered in Philadelphia with offices in Slough, UK. For more information, visit www.epharmasolutions.com or email info@epharmasolutions.com

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca
2. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
3. AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis
4. AstraZeneca Announces Results From Long-Term Safety Trial Of Naloxegol In Patients With Opioid-Induced Constipation
5. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
6. Isis Pharmaceuticals And AstraZeneca Form Strategic Alliance On RNA Therapeutics For Cancer
7. AstraZeneca And The Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents
8. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
9. Founded by Enlight Biosciences, KNODE partners with AstraZeneca and Other Partners
10. AstraZeneca and Leading Academic Scientists to Collaborate on Alzheimers Disease Research
11. AstraZeneca Acquires Neuroscience Assets From Link Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... SEATTLE , Jan. 24, 2017  CTI BioPharma ... that Michael A. Metzger has been appointed ... experience leading and growing companies in the biopharmaceutical industry ... pleased to welcome Michael to the Board of CTI ... CEO of CTI BioPharma. "Michael is an accomplished leader ...
(Date:1/24/2017)... 24, 2017 When tragedy strikes, victims often can,t communicate, ... conditions they have, and who back home is wondering about them. ... informed about the safety of their family and friends, while helping ... in times of crisis. ... If you find yourself or your family in one of ...
(Date:1/24/2017)... 24, 2017 Trifecta Clinical , a ... appointing Rick Ward to Vice President of ... is also announcing the promotion of Ericka Atkinson ... Rick joins Trifecta from Greenphire where he ... senior business development positions within the healthcare industry throughout ...
Breaking Medicine Technology:
(Date:1/24/2017)... Santa Rosa, California (PRWEB) , ... January 24, 2017 , ... ... named Cary McNamara as chief financial officer. , “Cary’s broad financial ... individual who possesses both the strategic planning and day-to-day financial operations skills we need ...
(Date:1/24/2017)... ... January 24, 2017 , ... The Cruise Web ... as part of the line’s 4th Annual MSC True Partnerships’ Awards. , ... American travel partners for the year based on overall business growth in revenue and ...
(Date:1/24/2017)... Baltimore, MD (PRWEB) , ... January 24, 2017 ... ... applicants to advance to the semi-final round of the 2017 Cupid's Cup Entrepreneurship ... competition celebrates its 12th year in 2017. The entrepreneurs will showcase their businesses ...
(Date:1/24/2017)... ... January 24, 2017 , ... West’s Health ... annual Solutions Series of webinars will start January 31 with a session about ... of current health and benefits topics, including employee engagement, pricing transparency, population health ...
(Date:1/24/2017)... ... , ... His message has been heard by more than 100,000 students and ... , Joel Feldman, has reached his biggest national audience yet: the three million daily ... newspapers in circulation in the country, and he hopes it will help spread his ...
Breaking Medicine News(10 mins):